Press Play with Madeleine Brand

First FDA-approved CRISPR treatment: What are ethical concerns?

A groundbreaking approval from the FDA allows the gene-editing tool CRISPR to treat sickle cell disease. But many unknowns exist in using CRISPR to treat illnesses.

By Madeleine Brand • Dec 13, 2023 • 1 min read

A groundbreaking approval from the FDA allows the gene-editing tool CRISPR to treat sickle cell disease. But many unknowns exist in using CRISPR to treat illnesses.

Madeleine Brand
Host, 'Press Play'
Sarah Sweeney
Vice President of Talk Programming, KCRW
Angie Perrin
Producer, Press Play
Michell Eloy
Line Editor, Press Play
Brendan Parent
assistant professor of medical ethics at NYU Grossman School of Medicine; director of transplant ethics and policy research

Press Play with Madeleine Brand

First FDA-approved CRISPR treatment: What are ethical concerns?

A groundbreaking approval from the FDA allows the gene-editing tool CRISPR to treat sickle cell disease. But many unknowns exist in using CRISPR to treat illnesses.

Share

Press Play with Madeleine Brand

First FDA-approved CRISPR treatment: What are ethical concerns?

A groundbreaking approval from the FDA allows the gene-editing tool CRISPR to treat sickle cell disease. But many unknowns exist in using CRISPR to treat illnesses.

Share